Izuralimab

Modify Date: 2024-01-16 22:17:11

Izuralimab Structure
Izuralimab structure
Common Name Izuralimab
CAS Number 2329669-80-7 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Izuralimab


Izuralimab is a bispecific IgG1 antibody targeting inducible T-cell costimulator (ICOS/CD278) and PD-1[1].

 Names

Name Izuralimab

 Izuralimab Biological Activity

Description Izuralimab is a bispecific IgG1 antibody targeting inducible T-cell costimulator (ICOS/CD278) and PD-1[1].
Related Catalog
Target

ICOS/CD278, PD-1[1]

References

[1]. Aghanejad A, et al. A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors. Int J Biol Macromol. 2022 May 15;207:592-610.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties
Top Suppliers:I want be here

No recommended suppliers.


Get all suppliers and price by the below link:

Izuralimab suppliers

Izuralimab price

Hot Compounds More...
Dichloromethane
CAS#:75-09-2
Polyacrylic acid
CAS#:9003-01-4
sodium carbonate
CAS#:497-19-8
Silicon dioxide
CAS#:7631-86-9
Triethanolamine
CAS#:102-71-6
Demeton
CAS#:126-75-0
Water
CAS#:7732-18-5
4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9
Diclofenac sodium
CAS#:15307-79-6
Budesonide
CAS#:51372-29-3